TIM-3 inhibitors: a promising strategy for tumor immunotherapy

被引：1

作者：

Lu, Lu ^{[1
]}

Deng, Liufu ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Shanghai Frontiers Sci Ctr DrugTarget Identificat, Sch Pharmaceut Sci, Natl Key Lab Innovat Immunotherapy, Shanghai 200240, Peoples R China

来源：

TRENDS IN MOLECULAR MEDICINE | 2024年 / 30卷 / 03期

基金：

中国国家自然科学基金;

关键词：

D O I：

10.1016/j.molmed.2024.01.004

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Ma et al. recently reported a systematic screening of small -molecule compounds targeting the FG-CC' cleft of T cell immunoglobulin and mucin-containing molecule 3 (TIM3). They identified a functional Tim3 inhibitor, ML -T7, that, as a single agent or in combination with antiPD -1, demonstrated strong antitumor activity in preclinical mouse tumor models, supporting its poten

引用

页码：202 / 203

页数：2

共 50 条

[41] Identification of a novel small-molecule inhibitor targeting TIM-3 for cancer immunotherapy
Wu, Menghan
Wu, Aijun
Zhang, Xiangrui
Li, Yang
Li, Beibei
Jin, Shengzhe
Dong, Qingyu
Niu, Xiaoshuang
Zhang, Lihan
Zhou, Xiaowen
Du, Jiangfeng
Wu, Yahong
Zhai, Wenjie
Zhou, Xiuman
Qiu, Lu
Gao, Yanfeng
Zhao, Wenshan
[J]. BIOCHEMICAL PHARMACOLOGY, 2023, 212
[42] Structure-Based Rational Design of Constrained Peptides as TIM-3 Inhibitors
Abdel-Rahman, Somaya A.
Ovchinnikov, Victor
Gabr, Moustafa T.
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (06): : 806 - 813
[43] Taming dendritic cells with TIM-3: another immunosuppressive strategy used by tumors
Patel, J.
Bozeman, E. N.
Selvaraj, P.
[J]. IMMUNOTHERAPY, 2012, 4 (12) : 1795 - 1798
[44] Plasma soluble Tim-3 emerges as an inhibitor in sepsis: sepsis contrary to membrane Tim-3 on monocytes
Ren, F.
Li, J.
Jiang, X.
Xiao, K.
Zhang, D.
Zhao, Z.
Ai, J.
Hou, C.
Jia, Y.
Han, G.
Xie, L.
[J]. TISSUE ANTIGENS, 2015, 86 (05): : 325 - 332
[45] Tim-3 promotes maternal tolerance
Dempsey, Laurie A.
[J]. NATURE IMMUNOLOGY, 2017, 18 (11) : 1189 - 1189
[46] Tim-3, Lag-3, and TIGIT
Joller, Nicole
Kuchroo, Vijay K.
[J]. EMERGING CONCEPTS TARGETING IMMUNE CHECKPOINTS IN CANCER AND AUTOIMMUNITY, 2017, 410 : 127 - 156
[47] Role of TIM-3 in ovarian cancer
Y. Xu
H. Zhang
Y. Huang
X. Rui
F. Zheng
[J]. Clinical and Translational Oncology, 2017, 19 : 1079 - 1083
[48] Tim-3 promotes maternal tolerance
Laurie A. Dempsey
[J]. Nature Immunology, 2017, 18 : 1189 - 1189
[49] Role of TIM-3 in ovarian cancer
Xu, Y.
Zhang, H.
Huang, Y.
Rui, X.
Zheng, F.
[J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (09): : 1079 - 1083
[50] TIM-3 mediated enhancement of anti-tumor immune responses.
Helmich, BK
Yei, S
Kuchroo, FK
Carlo, DJ
Moll, T
[J]. CLINICAL IMMUNOLOGY, 2005, 115 : S36 - S36

← 1 2 3 4 5 →